(Date:5/16/2008)...e,s Bed & Back; Merger Sets Up Healthy Back a...hain, LORTON, Va., May 16 /PRNewswire/ -- Healthy... and workplace back wellness created an,ergonomic ... its rival,JoAnne,s Bed & Back. Healthy Back,s 18...es of $40million. JoAnne,s 16 mid-Atlantic stores,...
(Date:5/16/2008)...swire-USNewswire/ -- This release is,being sent in...ion with the,National Cancer Institute, part of th...the American Society of Clinical,Oncology meeting ...practice,in about 25 percent of patients with colo...the way colorectal cancers will be staged., * Thi...
(Date:5/16/2008)...rs gain benefit from calcitriol, an oral form , ...g activated vitamin D may cut the risk of death fo...sease by about one quarter, a new study suggests. ...atients, those being treated with calcitriol, an o... risk of death lowered by 26 percent when compared...
(Date:5/16/2008)...Raise $38 Million for Life-threatening,Disease, B...lkers in nearly,every state will raise funds for c... participating in GREAT STRIDES, the largest natio... announced today., May is National Cystic Fibrosi...tening genetic disease that causes fatal lung infe...
Breaking Medicine News(10 mins):Health News:The Back Wars Come to a Close 2Health News:New Method Proposed for Determining Which Patients Should Get Treatment for Colorectal Cancer 2Health News:Vitamin D Use Linked to Lower Mortality in Kidney Patients 2Health News:GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend 2...ile teenagers have a greater resistance to alcohol...nskaya and other researchers studied the effects o... teenagers and adults. The rats - chosen because ...ics that of humans - were dosed with alcohol and t...
...ions regarding booze often finds thousands in the ...erson// in authority ever raising eyebrows until r...t estimates prove that over forty two thousand Rus...d to alcoholism. However a closer scrutiny has als...
...ystem to undertake greater activities related to s... and benchmarks for evaluating and monitoring such...of sport as an instrument that can bring people to...ting, Indian delegate Mufti Mohammed Sayeed said F...
...t six doctors of Indraprastha Apollo Hospital in ...e// for destruction of evidence related to Rahul M...-- Anupam Sibal, Prasad Rao, Awdesh Bansal, Mukund...Gupta. Six other staff of the hospital were also ...
Other Medicine News:Health News:Older People Get Worse Hangovers 2(Date:5/15/2008)... BONITA SPRINGS, Fla., May 15 /- Tigr...tion of a Cooperative Research and,Development Agr...(NCI) to,collaborate on clinical and preclinical d...n Phase I development. AFP-464 is converted to,met...n p53 activation and,apoptosis., This is part of ...
(Date:5/15/2008)...siderable Opportunity Remains for an Antiplatelet ...Bleeding than the Combination of Plavix/Iscover ...sion Resources, WALTHAM, Mass., May 15 /PRNewswir...ng research and advisory firms for pharmaceutical ...li Lilly,s Effient offers,improvement in patient c...
(Date:5/15/2008)...op Line Data Expected soon after CEA Trial data re... -, SAN FRANCISCO, May 15 /PRNewswire-First...), a biotechnology company focused on the developm...ar disease, announced today that,it has completed ...(ACS),study. The ACS study is one of three Phase 2...
(Date:5/15/2008)...- Data Presented at the 21st Annual Meeting of The...gy/Oncology (ASPHO) Meeting -, IRVINE, Calif., Ma...he,Company) (Nasdaq: IDMI ) today announced the p...ccess program evaluating mifamurtide (L-MTP-PE) in...progression of,osteosarcoma, a rare and often fata...
Breaking Medicine Technology:Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 2IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 3IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 4IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 5IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 6New portrait of Earth shows land cover as never before 14518 1New portrait of Earth shows land cover as never before 14518 2New Robotic Imaging Technology Holds Promise of Improved Cancer Care 4016 1New Robotic Imaging Technology Holds Promise of Improved Cancer Care 4016 2New Robotic Imaging Technology Holds Promise of Improved Cancer Care 4016 3New Robotic Imaging Technology Holds Promise of Improved Cancer Care 4016 4PharmMDs Brad Tice Named APhA Fellow 14511 1PharmMDs Brad Tice Named APhA Fellow 14511 2PharmMDs Brad Tice Named APhA Fellow 14511 3Controlling a sea of information 2523 1Controlling a sea of information 2523 2...erican Heart Journal , ,WINNIPEG, Manitoba - (Jul...ardiovascular focused, biopharmaceutical company,...ts from the,STRATEGY (Single High-Dose Bolus Tirof...and Bare Metal Stent In Acute Myocardial,Infarctio... Journal,of the American College of Cardiology (JA...
...wswire/ -- Phase 3 results,from the RE-NOVATE(TM) ...once daily, administered for an average of 33 days...d for an average of 33,days, in preventing venous ...r total hip replacement surgery. In this trial, th...n etexilate was,similar to enoxaparin. The inciden...
Other Medicine Technology:Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 2Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 3Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 4Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 5Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 2Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 3Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 4Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 5... program offers state-of-the-art quality in an ins...g strength and durability. Low profile cutting tip... Series I instruments are available in just about ...or large and small joint arthroscopic procedures.,...
... program offers state-of-the-art quality in an ins...g strength and durability. Low profile cutting tip... Series I instruments are available in just about ...or large and small joint arthroscopic procedures.,...
... program offers state-of-the-art quality in an ins...g strength and durability. Low profile cutting tip... Series I instruments are available in just about ...or large and small joint arthroscopic procedures.,...
... program offers state-of-the-art quality in an ins...g strength and durability. Low profile cutting tip... Series I instruments are available in just about ...or large and small joint arthroscopic procedures.,...
Medicine Products: